(Press-News.org) New Rochelle, NY, August 25, 2014—In a closed-loop control approach to managing type 1 diabetes, glucose sensors placed under the skin continuously monitor blood sugar levels, triggering the release of insulin from an implantable insulin pump as needed. The aim of this closed-loop insulin delivery system is improved control of blood glucose levels throughout the day and night. But a new study in adults and adolescents found that mean blood glucose levels remained at safe levels 53-82% of the time, according to the results published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the DTT website at http://online.liebertpub.com/doi/full/10.1089/dia.2014.0066 until September 25, 2014.
Howard Zisser, MD and an international team of researchers representing the Control to Range Study Group measured plasma glucose levels every 15-30 minutes in a group of individuals with type 1 diabetes who participated in the "Control to Range" multinational artificial pancreas study. They monitored the adults and teens over 22 hours, including three meals and periods of day and night. The authors describe the risks of hypo- and hyperglycemia, the variability between participants, and the differences in daytime/nighttime results, and also propose improvements needed in the design and implementation of closed-loop systems in the article "Multicenter Closed-Loop Insulin Delivery Study Points to Challenges for Keeping Blood Glucose in a Safe Range by a Control Algorithm in Adults and Adolescents with Type 1 Diabetes from Various Sites".
"It appears that we are getting closer to an Artificial Pancreas option for patients with type 1 diabetes," says DTT Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver. "The first version may need to be a hybrid system in which meals and exercise are announced with necessary dose adjustments along with Automatic Threshold Suspend for hypoglycemia."
INFORMATION:
About the Journal
Diabetes Technology & Therapeutics (DTT) is a monthly peer-reviewed journal that covers new technology and new products for the treatment, monitoring, diagnosis, and prevention of diabetes and its complications. Led by Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver, the Journal covers topics that include noninvasive glucose monitoring, implantable continuous glucose sensors, novel routes of insulin administration, genetic engineering, the artificial pancreas, measures of long-term control, computer applications for case management, telemedicine, the Internet, and new medications. Tables of content and a sample issue may be viewed on the Diabetes Technology & Therapeutics (DTT) website at http://www.liebertpub.com/DTT. DTT is the official journal of the Advanced Technologies & Treatments for Diabetes (ATTD) Conference.
About ATTD
The International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) presents top-caliber scientific programs that have provided participants with cutting-edge research and analysis into the latest developments in diabetes-related technology. A unique and innovative conference, ATTD brings the world's leading researchers and clinicians together for a lively exchange of ideas and information related to the technology, treatment, and prevention of diabetes and related illnesses.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Thyroid, Metabolic Syndrome and Related Disorders, Journal of Aerosol Medicine and Pulmonary Drug Delivery, Childhood Obesity, and Population Health Management. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website at http://www.liebertpub.com.
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 http://www.liebertpub.com
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
Contact: Kathryn Ryan, Mary Ann Liebert, Inc., (914) 740-2100, kryan@liebertpub.com
Do closed-loop insulin delivery systems improve blood glucose control in type 1 diabetes?
2014-08-25
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Study shows promise in automated reasoning, hypothesis generation over complete medical literature
2014-08-25
HOUSTON – (Aug. 25, 2014) – With approximately 50 million scientific papers available in public databases– and a new one publishing nearly every 30 seconds – scientists cannot know about every relevant study when they are deciding where to take their research next.
A new tool in development by computational biologists at Baylor College of Medicine and analytics experts at IBM research and tested as a "proof-of-principle" may one day help researchers mine all public medical literature and formulate hypotheses that promise the greatest reward when pursuing new scientific ...
EARTH Magazine: Changing the landscape: Geoscientists embrace 3-D printing
2014-08-25
Alexandria, Va. — The rapid proliferation of 3-D printing technology in the early 2000s sent ripples of excitement through the tech world and beyond, but the high price of printers put them out of reach for most academic researchers and hobbyists. Now, more affordable printers have broken this barrier, and geoscientists have started testing the waters.
From the delicate geometry of a crystal lattice to the sweeping strata of an anticline, geology is an inherently 3-D discipline. Three-dimensional printing offers the chance to make those structures replicable, communicable ...
Acrylamide exposure impairs blood-cerebrospinal fluid barrier function
2014-08-25
The blood-brain barrier prevents xenobiotics from entering the central nervous system. Growing evidence indicates that neurotoxins, such as tributyltin, manganese and nanoparticles, may disrupt the function of the blood-brain and blood-cerebrospinal fluid (CSF) barriers. Previous studies show that chronic acrylamide exposure leads to central and peripheral neuropathy. However, very few studies have focused on the effects of acrylamide exposure on these barriers. Prof. Yanshu Zhang and co-workers from Hebei United University in China found that acrylamide exposure damages ...
Deploying exosomes to win a battle of the sexes
2014-08-25
There are many biological tools that help animals ensure reproductive success. A new study in The Journal of Cell Biology provides further detail into how one such mechanism enables male fruit flies to improve their odds by stopping females from mating with other flies.
In addition to sperm, semen carries products that foster sperm survival, promote egg fertilization, and serve other functions that optimize a male's chances of passing along his genes. In male fruit flies, for example, reproductive accessory glands (thought to be equivalent to the prostate gland in humans) ...
Changes in the eye can predict changes in the brain
2014-08-25
Researchers at the Gladstone Institutes and University of California, San Francisco have shown that a loss of cells in the retina is one of the earliest signs of frontotemporal dementia (FTD) in people with a genetic risk for the disorder—even before any changes appear in their behavior.
Published today in the Journal of Experimental Medicine, the researchers, led by Gladstone investigator Li Gan, PhD and UCSF associate professor of neurology Ari Green, MD, studied a group of individuals who had a certain genetic mutation that is known to result in FTD. They discovered ...
Large-scale study focuses on heavy smokers
2014-08-25
It is a fact that smoking is harmful and associated with deadly diseases such as cancer and cardiovascular disease. Researchers also know that smokers die earlier than non-smokers. But a study that sheds light on the direct causal relationship between smoking and mortality by investigating genes has never been published before:
– We have studied 55,568 individuals, including 32,823 smokers who we followed for ten years. 3,430 died during this period. The epidemiological studies were supported by genetic analyses, and the conclusion is clear. Smoking is associated with ...
APOB, a gene involved in lipid transport, linked to cases of familial extreme longevity
2014-08-25
In a recent report in Aging Cell, a multidisciplinary team of Spanish scientists, led by Tim Cash and Manuel Serrano at the Spanish National Cancer Research Centre (CNIO), identify rare variants in the APOB gene in several families where exceptional longevity (>100 years of age) appears to cluster. Investigators identified three Spanish families with at least two siblings of around 100 years of age and they sequenced their genes in the hope of finding rare variants that could be associated with extreme longevity. Remarkably, only one gene was found carrying rare variants ...
Anticipating eperience-based purchases more enjoyable than material ones
2014-08-25
To get the most enjoyment out of our dollar, science tells us to focus our discretionary spending on trips over TVs, on concerts over clothing, since experiences tend to bring more enduring pleasure than do material goods. New research shows that the enjoyment we derive from experiential purchases may begin before we even buy.
The findings are published in Psychological Science, a journal of the Association for Psychological Science.
This research offers important information for individual consumers those who are trying to "decide on the right mix of material and experiential ...
Singaporean university launches world's 1st ZigBee-based inter-satellite comms system
2014-08-25
Engineers at the Nanyang Technological University in Singapore have successfully piloted the world's first ZigBee-based inter-satellite communication system.
The team at the Satellite Research Centre launched the VELOX-I, which consists of a nanosatellite weighing 3.5 kg and a piggyback picosatellite weighing 1.5 kg, from the two highest points on campus. Both miniature satellites were configured with a ZigBee wireless network and equipped with small sensor nodes that perform functions such as local sensing, distributed computing and data-gathering.
Designed to evaluate ...
UNC Lineberger researchers develop new approach to identify 'drivers' of cancer
2014-08-25
CHAPEL HILL, NC – UNC Lineberger Comprehensive Cancer Center researchers have developed a new integrated approach to pinpoint the genetic "drivers" of cancer, uncovering eight genes that could be viable for targeted breast cancer therapy.
The study, published online August 24 in Nature Genetics, was authored by Michael Gatza, PhD, lead author and post-doctoral research associate; Grace Silva, graduate student; Joel Parker, PhD, director of bioinformatics, UNC Lineberger; Cheng Fan, research associate; and senior author Chuck Perou, PhD, professor of genetics and pathology.
These ...